[1] SATTUI S E, SAAG K G. Fracture mortality: Associations with epidemiology and osteoporosis treatment[J].Nature Reviews Endocrinology, 2014, 10(Suppl 8): 592-602.
[2] HERNLUND E, SVEDBOM A, IVERGARD M, et al. Osteoporosis in the European Union: Medical management, epidemiology and economic burden[J].Archives of Oteoporosis, 2013, 8(1-2): 136.
[3] COSMAN F, BEUR S J D, LEBOFF M S, et al. Clinician’s guide to prevention and treatment of osteoporosis[J].Osteoporosis International, 2014, 25(10): 2 359-2 381.
[4] PACIFICI R. Bone remodeling and the microbiome[J].Cold Spring Harbor Perspectives in Medicine, 2017, 8(4): a031 203.
[5] SJOGREN K, ENGDAHL C, HENNING P, et al. The gut microbiota regulates bone mass in mice[J].Journal of Bone and Mineral Research, 2012, 27(6): 1 357-1 367.
[6] ZHANG J, LU Y, WANG Y, et al. The impact of the intestinal microbiome on bone health[J].Intractable & Rare Diseases Research, 2018, 7(3): 148-155.
[7] HUANG Z, CHEN J, LI B, et al. Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice [J].Annals of the Rheumatic Diseases, 2020, 79(5): 646-656.
[8] TYAGI A M, YU M, DARBY T M, et al. The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression [J].Immunity, 2018, 49(6): 1-16.
[9] ZHANG J, MOTYL K J, IRWIN R, et al. Loss of bone and Wnt10b expression in male type 1 diabetic mice is blocked by the probiotic Lactobacillus reuteri[J].Endocrinology, 2015, 156(9): 3 169-3 182.
[10] PARVANEH K, EBRAHIMI M, SABRAN M R, et al. Probiotics (Bifidobacterium longum) increase bone mass density and upregulate Sparc and Bmp-2 genes in rats with bone loss resulting from ovariectomy[J/OL].BioMed Research International, 2015. DOI:10.1155/2015/897639.
[11] OHLSSON C, ENGDAHL C, FAK F, et al. Probiotics protect mice from ovariectomy-induced cortical bone loss[J].PLoS One, 2014, 9(3): e92 368.
[12] NILSSON A G, SUNDH D, BACKHED F, et al. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: A randomized, placebo-controlled, double-blind, clinical trial[J].Journal of Internal Medicine, 2018, 284(3): 307-317.
[13] SCHEPPER J D, IRWIN R, KANG J, et al. Probiotics in gut-bone signaling[J].Advances in Experimental Medicine & Biology, 2017, 1 033(1): 225-247.
[14] MCCABE L, BRITTON R A, PARAMESWARAN N. Prebiotic and probiotic regulation of bone health: Role of the intestine and its microbiome[J].Current Osteoporosis Reports, 2015, 13(6): 363-371.
[15] 翟齐啸. 乳酸菌减除镉危害的作用及机制研究[D]. 无锡: 江南大学, 2015.
[16] ZHAI Q, WANG G, ZHAO J, et al. Protective effects of Lactobacillus plantarum CCFM8610 against acute cadmium toxicity in mice[J].Applied and Environmental Microbiology, 2013, 79(5):1 508-1 515.
[17] ZHAI Q, WANG G, ZHAO J, et al. Protective effects of Lactobacillus plantarum CCFM8610 against chronic cadmium toxicity in mice indicate routes of protection besides intestinal sequestration[J].Applied and Environmental Microbiology, 2014, 80(13): 4 063-4 071.
[18] 王俊通. 产共轭亚油酸乳酸菌对DSS诱导小鼠结肠炎的改善作用[D]. 无锡: 江南大学, 2016.
[19] SAVILLE P D. Changes in skeletal mass and fragility with castration in the rat: A model of osteoporosis[J].Journal of the American Geriatrics Society, 1969, 17(2): 155-166.
[20] BARON R, HESSE E. Update on bone anabolics in osteoporosis treatment: Rationale, current status, and perspectives[J].Journal of Clinical Endocrinology & Metabolism, 2012, 97(2): 311-325.
[21] FAHMY S R, SOLIMAN A M, SAYED A A, et al. Possible antiosteoporotic mechanism of Cicer arietinum extract in ovariectomized rats[J].International Journal of Clinical & Experimental Pathology, 2015, 8(4): 3 477-3 490.
[22] ZHANG M, LI Y, MA Q, et al. Relevance of parathyroid hormone (PTH), vitamin 25 (OH) D3, calcitonin (CT), bone metabolic markers, and bone mass density (BMD) in 860 female cases[J].Clinical & Experimental Obstetrics & Gynecology, 2015, 42(2): 129-132.
[23] SANCHEZ A, BRUN L R, SALERNI H, et al. Effect of denosumab on bone mineral density and markers of bone turnover among postmenopausal women with osteoporosis[J].Journal of Osteoporosis, 2016, 2016: 1-6.
[24] RAEHTZ S, FEDORKO A, MCCABE L. Estrogen deficiency induced intestinal inflammation and permeability is linked with osteoporosis (488.8)[J].Faseb Journal, 2014(4):28.
[25] LI J Y, CHASSAING B, TYAGI A M, et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics[J].Journal of Clinical Investigation, 2016, 126(6): 2 049-2 063.
[26] ZEISSIG S, BURGEL N, GUNZEL D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn\"s disease[J].Gut, 2007, 56(1): 61-72.
[27] ULLUWISHEWA D, ANDERSON R C, MCNABB W C, et al. Regulation of tight junction permeability by intestinal bacteria and dietary components[J].Journal of Nutrition, 2011, 141(5): 769-776.
[28] WADAHIRAIKE O, IMAMOV O, HIRAIKE H, et al. Role of estrogen receptor β in colonic epithelium[J].Proc Nati Acade SCI·USA, 2006, 103(8): 2 959-2 964.
[29] NISSEN L, CHINGWARU W, SGORBATI B, et al. Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: A functional study in the small intestinal cell model[J].International Journal of Food Microbiology, 2009, 135(3): 288-294.
[30] LIU F, LI G, WEN K, et al. Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probiotics [J].Viral Immunology, 2010, 23(2): 135-149.
[31] GILL H S, RUTHERFURD K J, PRASAD J, et al. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019)[J].British Journal of Nutrition, 2000, 83(2): 167-176.
[32] GAREAU M G, SHERMAN P M, WALKER W A. Probiotics and the gut microbiota in intestinal health and disease [J].Nature Reviews Gastroenterology and Hepatology, 2010, 7(9): 503-514.
[33] POLAT B, HALICI Z, CADIRCI E, et al. The effect of alpha-lipoic acid in ovariectomy and inflammation-mediated osteoporosis on the skeletal status of rat bone[J].European Journal of Pharmacology, 2013, 718(1-3): 469-474.
[34] JULES J, FENG X. In vitro investigation of the roles of the proinflammatory cytokines tumor necrosis factor-α and interleukin-1 in murine osteoclastogenesis[J].Methods in Molecular Biology, 2014, 1 155: 109-123.
[35] 钱兴皋, 刘宇恒, 王琴, 等. 炎症因子对骨质疏松症发病影响的研究进展[J].中国康复理论与实践, 2013,19(7): 51-52.
[36] 杨明园, 李超, 李明. 细胞因子与绝经后骨质疏松症关系的研究进展[J].中国骨质疏松杂志, 2014(6): 698-705.
[37] MIHARA M, HASHIZUME M, YOSHIDA H, et al. IL-6/IL-6 receptor system and its role in physiological and pathological conditions[J].Clinical Science, 2012, 122(4): 143-159.
[38] CZEMY B, KAMINSKI A, KURZAWSKI M, et al. The association of IL-1β, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women[J].European Journal of Obstetrics & Gynecology and Reproductive Biology, 2010, 149(1): 82-85.
[39] 任大勇. 益生乳酸杆菌的黏附及免疫调节作用研究[D]. 长春: 吉林大学, 2013.
[40] KO J S,YANG H R,CHANG J Y, et al. Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-α[J].World Journal of Gastroenterology, 2007, 13(13): 1 962-1 965.
